title: The carboxyl-terminal domain of closely related endotoxin-binding proteins determines the target of protein-lipopolysaccharide complexes.
abstract: The bactericidal/permeability increasing (BPI) and lipopolysaccharide (LPS)-binding (LBP) proteins are closely related two-domain proteins in which LPS binding is mediated by the NH(2)-terminal domain. To further define the role of the COOH-terminal domain of these proteins in delivery of LPS to specific host acceptors, we have compared interactions of LBP, BPI, LBP(N)-BPI(C) (NH(2)-terminal domain of LBP, COOH-terminal domain of BPI), and BPI(N)-LBP(C) with purified (3)H-LPS and, subsequently, with purified leukocytes and soluble (s)CD14. The COOH-terminal domain of LBP promotes delivery of LPS to CD14 on both polymorphonuclear leukocytes and monocytes resulting in cell activation. In the presence of Ca(2+) and Mg(2+), LBP and BPI each promote aggregation of LPS to protein-LPS aggregates of increased size (apparent M(r) > 20 x 10(6) Da), but only LPS associated with LBP and BPI(N)-LBP(C) is disaggregated in the presence of CD14. BPI and LBP(N)-BPI(C) promote apparently CD14-independent LPS association to monocytes without cell activation. These findings demonstrate that the carboxyl-terminal domain of these closely related endotoxin-binding proteins dictates the route and host responses to complexes they form with endotoxin.
authors.affiliation: Department of Medicine, New York University School of Medicine, New York, New York 10016, USA.
authors.forename: Nicole
authors.initials: N
authors.lastname: Iovine
authors.forename: Joshua
authors.initials: J
authors.lastname: Eastvold
authors.forename: Peter
authors.initials: P
authors.lastname: Elsbach
authors.forename: Jerrold P
authors.initials: JP
authors.lastname: Weiss
authors.forename: Theresa Lee
authors.initials: TL
authors.lastname: Gioannini
mesh_terms: D000166:Acridines / Q000494:pharmacology; D000209:Acute-Phase Proteins; D002352:Carrier Proteins / Q000737:chemistry* / Q000378:metabolism; D002845:Chromatography; D002850:Chromatography, Gel; D004305:Dose-Response Relationship, Drug; D004926:Escherichia coli / Q000378:metabolism; D006801:Humans; D007962:Leukocytes / Q000378:metabolism; D018950:Lipopolysaccharide Receptors / Q000096:biosynthesis; D008070:Lipopolysaccharides / Q000737:chemistry*; D008562:Membrane Glycoproteins; D009000:Monocytes / Q000378:metabolism; D009504:Neutrophils / Q000378:metabolism; D011485:Protein Binding; D017434:Protein Structure, Tertiary; D011994:Recombinant Proteins / Q000378:metabolism; D013329:Structure-Activity Relationship; D013997:Time Factors; D000099231:Lipopolysaccharide-Binding Protein
chemical_list: D000166:Acridines; D000209:Acute-Phase Proteins; D002352:Carrier Proteins; D018950:Lipopolysaccharide Receptors; D008070:Lipopolysaccharides; D008562:Membrane Glycoproteins; D011994:Recombinant Proteins; D000099231:Lipopolysaccharide-Binding Protein; C033472:10,10'-dimethyl-9,9'-biacridinium